Product Information
DEXTROAMP-AMPHETAMIN 15 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2370 per EA under NDC 68462065101. Its NADAC has been published 61 times since Jun 25, 2025.
FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 15 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462065101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE DL-ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210754FDA Approved
7/5/2022
TE Code
AB
On Market Since
5/12/2025
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has been published 61 times since Jun 25, 2025, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2370 per EA |
|---|---|
| All-time high | $0.2936 (Feb 11, 2026) |
| All-time low | $0.2370 (Aug 19, 2026) |
| 52-week high | $0.2936 |
| 52-week low | $0.2370 |
| Median price | $0.2635 |
| Average price | $0.2624 |
| Largest weekly change | -6.9% (Feb 18, 2026) |
| Weeks tracked | 61 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 15 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 15 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2370 per EA (NDC 68462065101), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 15 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has declined 14.1%. It has been tracked across 61 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 15 MG TAB?
Since Jun 25, 2025, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has ranged from a low of $0.2370 (Aug 19, 2026) to a high of $0.2936 (Feb 11, 2026), with a median of $0.2635 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 15 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 15 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 15 MG TAB?
DEXTROAMP-AMPHETAMIN 15 MG TAB (NDC 68462065101) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.